Risks of allergy vial contamination: Comparison of mixing in-office versus under ventilation hood

Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 3, 2008, Pages 364-366

  Lay, P Chase ^a   Bass, Richard ^a   Hughes, Larry F ^a   Lin, Sandra Y ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBE; ALLERGY; ANAEROBE; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; FOLLOW UP; IMMUNOTHERAPY; INFECTION RISK; INSTRUMENT STERILIZATION; INTERMETHOD COMPARISON; OUTPATIENT; PROSPECTIVE STUDY; SKIN INFECTION; SYMPTOMATOLOGY;

ALLERGENS; DRUG CONTAMINATION; DRUG PACKAGING; HUMANS; IMMUNOTHERAPY; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; VENTILATION;

EID: 49549100491     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2008.06.016     Document Type: Article

References (12)

1. Lin S.Y., Houser S.M., and Rodriguez H.P. The implications of regulatory guidelines for the practicing otolaryngologist. Otolaryngol Head Neck Surg 136 (2007) 1017-1018
2. Lay P.C., Bass R., and Lin S.Y. Allergen vial mixing and immunotherapy: risk of infection and vial contamination. Otolaryngol Head Neck Surg 137 (2007) 243-245
3. Lockey R. Adverse skin reactions associated with skin testing and immunotherapy. Allergy Proc 16 (1995) 292-296
4. US Pharmacopeial Convention, Inc. Chapter 797 Pharmaceutical compounding sterile preparations. US Pharmacopeia 28 (2004), US Pharmacopeial Convention, Rockville (MD) 2461-2477
5. US Pharmacopeial Convention, Inc. Chapter 797 Pharmaceutical compounding sterile preparations. Pharmacopeial Forum May-June 34 3 (2008) 334-351
6. King H.C., Mabry R.L., and Mabry C.S. Allergy in ENT practice: a basic guide (1998), Thieme, New York 200-249
7. Hintz J. NCSS, PASS, & GESS (2007), NCSS, Kaysville (UT)
8. Ahmed K., Roberts M.L., and Mannion P.T. Antimicrobial activity of glycerine-ichthammol in otitis externa. Clin Otolaryngol 20 (1995) 201-203
9. Iglesias-Cadarso A., Hernandez-Weigand P., Reano M., et al. A prospective safety study of allergen immunotherapy in daily clinical practice. Allergol Immunopathol 32 (2004) 278-283
10. Norman P.S., and Van Metre T.E. The safety of allergenic immunotherapy. J Allergy Clinic Immunol 85 (1999) 522-525
11. Ragusa V.F., and Massolo A. Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods. Eur Ann Allergy Clin Immunol 36 (2004) 52-55
12. Lin M.S., Tanner E., Lynn J., et al. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy. Ann Allergy 71 (1993) 557-562